CTCFL and melanoma: These studies found that BORIS transcript expression was not as frequent in primary melanomas (27%) [14], [20], [22] as originally estimated for melanoma cell lines (90%) [14], [20], [22], and when measured quantitatively, levels in tumors were not statistically different from those in normal prostate, bladder, and ovarian tissues [14], [20], [22].